Allied Market Research
Loading...
0
Upcoming Allied Market Research
2021
Diagnostic Biomarkers Market

Diagnostic Biomarkers Market by Product Type (Safety Biomarker, Efficacy Biomarker, and Validation Biomarker), Application (Drug Discovery & Development, Diagnostic, Disease Risk Assessment, Personalized Medicine, and Others), End User (Hospitals, Cancer Research Institutes, and Diagnostic Labs): Global Opportunity Analysis and Industry Forecast, 2021–2030

A13936
Pages: NA
Dec 2021 | 134 Views
   
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Diagnostic Biomarkers Market

Request Now !

Biomarkers are used for various purposes such as disease diagnosis, prognosis, prediction, and assessment of treatment response. Diagnostic biomarkers have early inferences for the detection of patent ductus arteriosus (PDA). Predictive markers provide personalized treatment regimens and prognostic markers predict patient survival and recurrence patterns.

Biomarkers are used for clinical diagnostics for detecting multiple diseases, for instance, creatinine for diagnosing renal insufficiency, troponin level for diagnosing myocardial infarction, and amylase for pancreatitis. Biomarkers provide an approach in understanding the dynamics of neurological disease with the contribution in applications of analytical epidemiology and clinical trials. Diagnostic biomarkers can extend the base of information of the underlying pathology of disease along with providing means for homogeneous classification of a disease's possible factors that are a risk for the body.

Market Scope and Structure Analysis

Report Metric

Details

  Market Size Available for Years

  2020–2030

  Base Year Considered

  2020

  Forecast Period 

  2021–2030

  Forecast Unit

  Value (USD)

  Segments Covered

  Product Type, Application, End User, and Region

  Regions Covered

  North America, Europe, Asia-Pacific, LAMEA

  Companies Covered

Qiagen N.V., Perkinelmer, Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Enzo Biochem, Inc., EKF Diagnostics Holdings, Inc., Meso Scale Diagnostics, LLC., Biosims Technologies Sas, Cisbio Bioassays, Signosis, Inc, Banyan Biomarkers, Inc, and Biomedical Corp.

 

COVID-19 Impact analysis

  • As the number of COVID-19 cases and deaths continue to rise steadily worldwide, the common goal of scientists, healthcare providers, and government officials worldwide has been to find the best way to detect and treat the viral infection of the COVID-19 virus.
  • Precise detection, effective treatment, timely diagnosis, and future prevention are the vital keys to the management of COVID-19, and can help curb the viral spread. Traditionally, biomarkers play a crucial role in the early detection of disease etiology, diagnosis, and treatment. Therefore, COVID-19 has a positive impact on the diagnostic biomarkers market.

Top Impacting Factors
High prevalence of cancer and other chronic disorders is the key driver for market growth.
Increasing diagnostic applications of biomarkers and rising R&D funding for pharma and biotech companies are few factors responsible for propelling the diagnostic biomarkers market growth. 
Moreover, low cost of clinical trials in developing countries and new initiatives for research contribute toward the growth of the global diagnostic biomarkers market. 
Biomarkers are prominently used in application areas such as personalized medicines, companion diagnostics, and other diagnostic areas, including drug discovery & development and disease risk assessment. These increasing diagnostic applications of biomarkers are expected to drive market growth in the forecasted years. 
Advancements in laboratory techniques and expansion of the molecular biology sector are other key factors stimulating the growth of the diagnostic biomarker market.
On the other hand, poorly suited regulatory and reimbursement systems, high capital investments, low cost-benefit ratio, and technical issues related to sample collection & storage are the major factors restraining the growth of this market.

Market Trends
New product launches to flourish the market

  • On August 27, 2020, a U.S.-based software company, Translational Imaging Innovations Inc., which is fast-tracking the development of diagnostic biomarkers of eye disease via its novel image management & analytics software, announced that it had been awarded an SBIR (Small Business Innovation Research) award, worth USD 1.5 million by the National Eye Institute of the NIH. 
  • On August 5, 2020, an Israeli start-up, Sight Diagnostics, developing a machine-vision-based finger-prick analysis device, announced that it had raised USD 71 million in Series D funding. The company suggests that its platform may offer a significant role in the early detection of conditions such as cancer, sepsis, and is currently investigated for potential use in monitoring biomarkers tied to the coronavirus severity.

Surge in usage due to cancer

  • Owing to the growing prevalence of cancer worldwide, the use of cancer biomarkers has increased significantly in recent years, providing opportunities for improving the management of cancer patients by enhancing detection and efficacy of treatment. Cancer biomarkers are present in tumor tissues or sera and encompass a wide variety of molecules, including mRNA, DNA, transcription factors, cell surface receptors, and secreted proteins. These biomarkers can be used for the prognosis and predicting the natural course of a tumor. They can further help doctors decide which patients are likely to respond to a given drug (prediction) and at what dosage it might be most effective (pharmacodynamics).

Key Segments Covered

Segment

Subsegment

  Product Type

  • Safety Biomarkers
  • Efficacy Biomarkers
  • Validation Biomarkers

  Application

  • Drug Discovery and Development
  • Diagnostic
  • Disease Risk Assessment
  • Personalized Medicine
  • Others

  End User

  • Hospitals
  • Cancer Research Institutes
  • Diagnostic Labs

  Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

Key Benefits of the Report

  • This study presents the analytical depiction of the diagnostic biomarkers along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the diagnostic biomarkers market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the diagnostic biomarkers market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed diagnostic biomarkers market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Diagnostic Biomarkers Report

  • Who are the leading market players active in the diagnostic biomarkers market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
  • What is "diagnostic biomarkers "?
  • What is "diagnostic biomarkers " market prediction in the future?
  • Who are the leading global players in the "diagnostic biomarkers " market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "diagnostic biomarkers " market report?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Diagnostic Biomarkers Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995  $8,996
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers